Provided by Tiger Fintech (Singapore) Pte. Ltd.

Phreesia, Inc.

23.97
+0.08000.33%
Post-market: 23.970.00000.00%18:47 EDT
Volume:486.23K
Turnover:11.59M
Market Cap:1.41B
PE:-23.59
High:24.20
Open:23.74
Low:23.03
Close:23.89
Loading ...

Q3 2025 Phreesia Inc Earnings Call

Thomson Reuters StreetEvents
·
10 Dec 2024

Phreesia Price Target Maintained With a $29.00/Share by Needham

Dow Jones
·
10 Dec 2024

Phreesia Inc (PHR) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Positive Cash Flow

GuruFocus.com
·
10 Dec 2024

Phreesia (PHR) Reports Q3 Earnings: What Key Metrics Have to Say

Zacks
·
10 Dec 2024

Phreesia (PHR) Reports Q3 Loss, Tops Revenue Estimates

Zacks
·
10 Dec 2024

Phreesia Inc reports results for the quarter ended October 31 - Earnings Summary

Reuters
·
10 Dec 2024

Phreesia: Fiscal Q3 Earnings Snapshot

Associated Press Finance
·
10 Dec 2024

Phreesia Fiscal Q3 Loss Narrows, Revenue Rises; FY 2025 Revenue Outlook Narrows; Stock Gains After Hours

MT Newswires Live
·
10 Dec 2024

Phreesia Share up 1.8% After the Bell Following Results

THOMSON REUTERS
·
10 Dec 2024

Phreesia Q3 EPS USD -0.25

THOMSON REUTERS
·
10 Dec 2024

Phreesia Q3 2025 GAAP EPS $(0.25) Beats $(0.27) Estimate, Sales $106.80M Beat $106.33M Estimate

Benzinga
·
10 Dec 2024

Phreesia Inc Q3 Shr View $-0.27, REV View $106.3 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
10 Dec 2024

Phreesia Inc : Qtrly Shr Loss $ (0.25

THOMSON REUTERS
·
10 Dec 2024

Phreesia Inc : Qtrly Total Revenue Was $106.8 Mln

THOMSON REUTERS
·
10 Dec 2024

Phreesia Inc - Introduces Fiscal 2026 Revenue Outlook of $472 Million-$482 Million

THOMSON REUTERS
·
10 Dec 2024

Phreesia Inc FY2025 REV View $419.2 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
10 Dec 2024

Phreesia Inc FY2026 REV View $480.9 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
10 Dec 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
09 Dec 2024

Curious about Phreesia (PHR) Q3 Performance? Explore Wall Street Estimates for Key Metrics

Zacks
·
06 Dec 2024

Analysts Offer Insights on Healthcare Companies: Phreesia (PHR), Larimar Therapeutics (LRMR) and Merus (MRUS)

TIPRANKS
·
06 Dec 2024